Cullen Frost Bankers Inc. lessened its stake in CME Group Inc (NASDAQ:CME) by 10.5% during the fourth quarter, HoldingsChannel reports. The firm owned 1,916 shares of the financial services provider’s stock after selling 224 shares during the period. Cullen Frost Bankers Inc.’s holdings in CME Group were worth $360,000 as of its most recent SEC filing.
Several other institutional investors also recently modified their holdings of the company. First Hawaiian Bank purchased a new stake in shares of CME Group in the third quarter worth $554,000. BB&T Corp grew its stake in shares of CME Group by 8.2% in the third quarter. BB&T Corp now owns 4,546 shares of the financial services provider’s stock worth $774,000 after acquiring an additional 343 shares during the last quarter. Huntington National Bank grew its stake in shares of CME Group by 31.9% in the third quarter. Huntington National Bank now owns 2,189 shares of the financial services provider’s stock worth $373,000 after acquiring an additional 530 shares during the last quarter. IFM Investors Pty Ltd grew its stake in shares of CME Group by 16.9% in the third quarter. IFM Investors Pty Ltd now owns 17,867 shares of the financial services provider’s stock worth $3,041,000 after acquiring an additional 2,579 shares during the last quarter. Finally, Calamos Advisors LLC purchased a new stake in shares of CME Group in the third quarter worth $5,276,000. Institutional investors and hedge funds own 90.59% of the company’s stock.
Get CME Group alerts:
In other CME Group news, Chairman Terrence A. Duffy sold 10,000 shares of the stock in a transaction dated Friday, November 23rd. The stock was sold at an average price of $188.80, for a total value of $1,888,000.00. Following the transaction, the chairman now owns 95,652 shares of the company’s stock, valued at $18,059,097.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Charles P. Carey sold 5,000 shares of the stock in a transaction dated Wednesday, November 21st. The shares were sold at an average price of $191.84, for a total value of $959,200.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 46,647 shares of company stock worth $8,827,628. Corporate insiders own 0.43% of the company’s stock.
Shares of NASDAQ:CME opened at $175.40 on Monday. The firm has a market cap of $59.61 billion, a PE ratio of 36.77, a price-to-earnings-growth ratio of 2.21 and a beta of 0.30. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.09 and a current ratio of 1.09. CME Group Inc has a 1 year low of $153.90 and a 1 year high of $197.08.
CME Group (NASDAQ:CME) last announced its quarterly earnings results on Thursday, February 14th. The financial services provider reported $1.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.75 by $0.02. The firm had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.22 billion. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The company’s quarterly revenue was up 37.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.12 earnings per share. On average, research analysts predict that CME Group Inc will post 6.8 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be issued a dividend of $0.75 per share. This is an increase from CME Group’s previous quarterly dividend of $0.70. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date is Thursday, March 7th. CME Group’s dividend payout ratio is presently 58.70%.
A number of equities research analysts have recently commented on CME shares. Citigroup started coverage on CME Group in a research note on Tuesday, November 20th. They issued a “buy” rating and a $220.00 target price on the stock. Berenberg Bank raised CME Group from a “hold” rating to a “buy” rating and set a $220.00 target price on the stock in a research note on Tuesday, November 20th. Deutsche Bank increased their target price on CME Group from $205.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, November 16th. Bank of America reissued a “buy” rating and issued a $200.00 target price on shares of CME Group in a research note on Monday, November 5th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $204.00 target price on shares of CME Group in a research note on Wednesday, January 9th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and seven have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $193.47.
ILLEGAL ACTIVITY NOTICE: This news story was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark law. The legal version of this news story can be read at https://www.tickerreport.com/banking-finance/4160842/cme-group-inc-cme-stake-lessened-by-cullen-frost-bankers-inc.html.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Recommended Story: How to interpret the current ratio
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).